No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
STAA240517C60000
- 0.18
- -0.02-10.00%
15min DelayClose May 7 16:00 ET
0.18High0.18Low
0.18Open0.20Pre Close2 Volume31 Open Interest60.00Strike Price36.00Turnover91.30%IV28.94%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.18Time Value100Contract SizeAmericanOptions Type0.0540Delta0.0158Gamma311.00Leverage Ratio-0.0376Theta0.0006Rho16.78Eff Leverage0.0083Vega
Intraday
- 5D
- 1D
News
Staar Surgical Is Maintained at Buy by Mizuho
Staar Surgical Is Maintained at Buy by Mizuho
Staar Surgical Price Target Raised to $55.00/Share From $53.00 by Mizuho
Staar Surgical Price Target Raised to $55.00/Share From $53.00 by Mizuho
Mizuho Bank: Maintaining the Staar Surgical (STAA.US) rating, adjusted from buy to buy rating, and adjusted the target price from $53.00 to $55.00.
Mizuho Bank: Maintaining the Staar Surgical (STAA.US) rating, adjusted from buy to buy rating, and adjusted the target price from $53.00 to $55.00.
Mizuho Maintains Buy on Staar Surgical, Raises Price Target to $55
Mizuho analyst Anthony Petrone maintains Staar Surgical with a Buy and raises the price target from $53 to $55.
Staar Surgical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 22.22% Mizuho $53 → $55 Maintains Buy 04/11/2024 17.78% Mizuho $45 → $53 Maintains Buy 04/08/20
Morgan Stanley Raises Price Target on STAAR Surgical to $50 From $35, Keeps Equalweight Rating
STAAR Surgical (STAA) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $40 to $60.